Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 1.000 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.564 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.556 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.555 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.553 | |
1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.549 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.549 | |
1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.545 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.542 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.540 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.539 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.538 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.537 | |
2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.536 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.535 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.535 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.534 | |
2pul | ACP | Methylthioribose kinase | 2.7.1.100 | 0.534 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.533 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.533 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.533 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.532 | |
4wh3 | ATP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.531 | |
3q5i | ANP | Protein kinase, putative | / | 0.530 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.530 | |
3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.528 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.528 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.528 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.528 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.527 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.527 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.526 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.526 | |
4y12 | AGS | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.526 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.525 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.525 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.525 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.525 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.524 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.524 | |
2olc | ADP | Methylthioribose kinase | 2.7.1.100 | 0.523 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.523 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.523 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.522 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.522 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.521 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.521 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.521 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.521 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.520 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.519 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.519 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.519 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.518 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.518 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.518 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.518 | |
2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.518 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.518 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.518 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.518 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.518 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.518 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.518 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.517 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.517 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.517 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.517 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.516 | |
4eom | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.516 | |
2pui | ADP | Methylthioribose kinase | 2.7.1.100 | 0.515 | |
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.515 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.515 | |
4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.515 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.515 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.515 | |
4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.515 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.514 | |
3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.514 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.514 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.514 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.513 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.513 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.513 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.513 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.513 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.513 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.512 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.512 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.512 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.512 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.512 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.512 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.511 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.511 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.511 | |
4bhz | Z0B | Dual specificity protein kinase TTK | 2.7.12.1 | 0.511 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.511 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.510 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.510 | |
4f1s | F1S | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.510 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.510 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.510 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.509 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.509 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.509 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.509 | |
4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.509 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.508 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.508 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.508 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.508 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.507 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.507 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.507 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.506 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.506 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.506 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.505 | |
3orl | AGS | Serine/threonine protein kinase | / | 0.505 | |
4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.505 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.504 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.504 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.504 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.504 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.504 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.504 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.504 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.503 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.503 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.503 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.503 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.503 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.503 | |
4n6z | 2HW | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.503 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.502 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.502 | |
4bda | VFB | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.502 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.502 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.501 | |
2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.501 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.501 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.501 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.501 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.501 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.501 | |
3t8o | ATP | Rhodopsin kinase | / | 0.501 | |
4a9s | RU9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.501 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.501 | |
4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.501 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.501 | |
5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.501 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.500 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.500 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.500 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.500 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.500 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.500 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.500 | |
4n57 | ADP | APH(2'')-Id | / | 0.500 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.499 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.499 | |
3w0p | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.499 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.499 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.498 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.498 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.498 | |
3ori | AGS | Serine/threonine protein kinase | / | 0.498 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.498 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.498 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.498 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.498 | |
4ix5 | ANP | Uncharacterized protein | / | 0.498 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.497 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.497 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.497 | |
5dr2 | ATP | Aurora kinase A | 2.7.11.1 | 0.497 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.496 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.496 | |
3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.496 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
1g6c | IFP | Thiamine-phosphate synthase | / | 0.495 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.495 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.495 | |
2pup | ADP | Methylthioribose kinase | 2.7.1.100 | 0.495 | |
2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.495 | |
3amy | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.495 | |
3gu5 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.495 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.495 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.495 | |
4y0x | ADP | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.495 | |
1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.494 | |
2a4z | BYM | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.494 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.494 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.494 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.494 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.494 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.494 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.494 | |
4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.494 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.494 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.494 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.493 | |
1fpq | SAM | Isoliquiritigenin 2'-O-methyltransferase | / | 0.493 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.493 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.493 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.493 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.493 | |
3nsz | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.493 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.493 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.493 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.493 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.493 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.493 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.493 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.493 | |
1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.492 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.492 | |
2pml | ANP | Uncharacterized protein | / | 0.492 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.492 | |
2ym8 | YM8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.492 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.492 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.492 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.492 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.492 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.492 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.492 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.491 | |
1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.491 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.491 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.491 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.491 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.491 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.491 | |
1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.490 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.490 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.490 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.490 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.489 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.489 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.489 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.489 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.489 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
3r9n | Z68 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.489 | |
4dta | ADN | APH(2'')-Id | / | 0.489 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.489 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.489 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.489 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.488 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.488 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.488 | |
4d58 | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.488 | |
4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.488 | |
4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.488 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.488 | |
1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.487 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
3ork | AGS | Serine/threonine protein kinase | / | 0.487 | |
3qts | X46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.487 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.487 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.487 | |
1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.486 | |
1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.486 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.486 | |
2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.486 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.486 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.486 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.486 | |
4b8l | A0P | Aurora kinase B-A | 2.7.11.1 | 0.486 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
4gyi | ADP | Uncharacterized protein | / | 0.486 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.486 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.486 | |
4wbo | ANW | Rhodopsin kinase | / | 0.486 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.486 | |
1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.485 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.485 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.485 | |
2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.485 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.485 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.485 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.485 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
4ryv | ZEA | Protein LlR18A | / | 0.485 | |
5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.485 | |
2har | OCC | Vitamin D3 receptor | / | 0.484 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.484 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.484 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.484 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.484 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.484 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.484 | |
1ie4 | T44 | Transthyretin | / | 0.483 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.483 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.483 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.483 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.483 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.483 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.483 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.483 | |
4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.483 | |
1zlt | HYM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
3r0t | FU9 | Casein kinase II subunit alpha | 2.7.11.1 | 0.482 | |
3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.482 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.482 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.482 | |
4fz7 | 0VH | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.482 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.482 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.481 | |
1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.481 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.481 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.481 | |
3c4w | ATP | Rhodopsin kinase | / | 0.481 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.481 | |
3qru | X19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
3zvv | XAZ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.481 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.481 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.481 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.480 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.480 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.480 | |
2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.480 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.480 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.480 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.480 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.480 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.480 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
1mp8 | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.479 | |
1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
2c3i | IYZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.479 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.479 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
2zdu | 446 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.479 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.479 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.479 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.479 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.479 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.479 | |
4ux9 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.479 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.479 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.478 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.478 | |
2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.478 | |
2xuu | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.478 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.478 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.478 | |
3ls8 | AJZ | Phosphatidylinositol 3-kinase catalytic subunit type 3 | 2.7.1.137 | 0.478 | |
3qcx | 3Q2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
3r3f | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.478 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.478 | |
3unk | 0BY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.478 | |
4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.478 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.478 | |
4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.478 | |
4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.478 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.478 | |
4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.478 | |
1e5q | NDP | Saccharopine dehydrogenase [NADP(+), L-glutamate-forming] | 1.5.1.10 | 0.477 | |
1urw | I1P | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2bmc | MPY | Aurora kinase A | 2.7.11.1 | 0.477 | |
2c6d | ANP | Aurora kinase A | 2.7.11.1 | 0.477 | |
2c6m | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2pun | ACP | Methylthioribose kinase | 2.7.1.100 | 0.477 | |
2wtj | WTJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
3c4x | ATP | Rhodopsin kinase | / | 0.477 | |
3dat | MTX | Dihydrofolate reductase | / | 0.477 | |
3zc5 | W9Z | Hepatocyte growth factor receptor | 2.7.10.1 | 0.477 | |
4azw | ATP | O-antigen chain terminator bifunctional methyltransferase/kinase WbdD | / | 0.477 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.477 | |
4wq5 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.477 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.477 | |
5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.477 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.476 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.476 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.476 | |
2xiz | XIZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.476 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.476 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.476 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.476 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.476 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.476 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.476 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.476 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.476 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.476 | |
4zhq | ACP | Tubulin tyrosine ligase | / | 0.476 | |
1cqp | 803 | Integrin alpha-L | / | 0.475 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.475 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.475 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.475 | |
2zv2 | 609 | Calcium/calmodulin-dependent protein kinase kinase 2 | 2.7.11.17 | 0.475 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.475 | |
3nup | 3NU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.475 | |
3owl | 19E | Casein kinase II subunit alpha | 2.7.11.1 | 0.475 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.475 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.475 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.475 | |
5auz | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.475 | |
1m2q | MNX | Casein kinase II subunit alpha | 2.7.11.1 | 0.474 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.474 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.474 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
2xs0 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.474 | |
3kjr | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.474 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.474 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.474 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.474 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.474 | |
4ix4 | ADP | Uncharacterized protein | / | 0.474 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.474 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.473 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.473 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.473 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2xiy | XIY | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.473 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.473 | |
3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 | 0.473 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.473 | |
3r8p | Z46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.473 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.473 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.473 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.473 | |
4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.473 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.473 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.473 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.472 | |
2w4k | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.472 | |
3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.472 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.472 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.472 | |
4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.472 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
4ewn | 0VR | Imidazole glycerol phosphate synthase subunit HisF | 4.1.3 | 0.472 | |
4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.472 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.472 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
2hb7 | O1C | Vitamin D3 receptor | / | 0.471 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.471 | |
2jkq | VG8 | Focal adhesion kinase 1 | 2.7.10.2 | 0.471 | |
2pzi | AXX | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.471 | |
2r3q | 5SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.471 | |
4a6c | QG9 | Gag-Pol polyprotein | 3.4.23.16 | 0.471 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.471 | |
4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.471 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.471 | |
4eos | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4fhj | 0TZ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.471 | |
4hhz | 15S | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.471 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.471 | |
4o95 | 245 | Cytokinin dehydrogenase 4 | / | 0.471 | |
4q71 | FAD | Bifunctional protein PutA | / | 0.471 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.471 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.471 | |
1day | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.470 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.470 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
2jko | BIJ | Focal adhesion kinase 1 | 2.7.10.2 | 0.470 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.470 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.470 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
4af3 | VX6 | Aurora kinase B | 2.7.11.1 | 0.470 | |
4az0 | S61 | Lysosomal protective protein | 3.4.16.5 | 0.470 | |
4e1z | 0MX | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.470 | |
4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
4g3e | 0WC | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.470 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.470 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
5c03 | AGS | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.470 | |
1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.469 | |
1sn0 | T44 | Transthyretin | / | 0.469 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.469 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.469 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.469 | |
3dcv | 55E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
3n0t | OPY | Dipeptidyl peptidase 2 | 3.4.14.2 | 0.469 | |
3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.469 | |
3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.469 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.469 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.469 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.469 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.469 | |
1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.468 | |
1ie8 | KH1 | Vitamin D3 receptor | / | 0.468 | |
1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.468 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3c50 | ADP | Rhodopsin kinase | / | 0.468 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.468 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.468 | |
3icr | COA | Coenzyme A disulfide reductase | / | 0.468 | |
3ics | COA | Coenzyme A disulfide reductase | / | 0.468 | |
3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.468 | |
3qtr | X36 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3s0o | 50Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.468 | |
4fko | 20K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.468 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.468 | |
4ydu | ADP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.468 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.467 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
1ykd | CMP | Adenylate cyclase | / | 0.467 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.467 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.467 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.467 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
2rcy | NAP | Pyrroline-5-carboxylate reductase | / | 0.467 | |
2vtl | LZ5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
3d84 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.467 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
3v9y | 24L | Peroxisome proliferator-activated receptor gamma | / | 0.467 | |
3vrw | YS5 | Vitamin D3 receptor | / | 0.467 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.467 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.467 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.467 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.467 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.467 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.467 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.467 | |
5j23 | A2R | Putative 2-hydroxyacid dehydrogenase | / | 0.467 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.466 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
1s19 | MC9 | Vitamin D3 receptor | / | 0.466 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.466 | |
2hcd | BIV | Vitamin D3 receptor A | / | 0.466 | |
2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.466 | |
2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
3a8t | ATP | Adenylate isopentenyltransferase | / | 0.466 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.466 | |
3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.466 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.466 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.466 | |
3orp | AGS | Serine/threonine protein kinase | / | 0.466 | |
3rjc | 06Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
3unj | 0BX | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.466 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.466 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.466 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.466 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.466 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.466 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.466 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.466 | |
1db1 | VDX | Vitamin D3 receptor | / | 0.465 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.465 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2cn8 | DBQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.465 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.465 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.465 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
3eb0 | DRK | Uncharacterized protein | / | 0.465 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.465 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
3q9y | TXQ | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
4ez7 | 2AN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.465 | |
4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.465 | |
4l23 | X6K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.465 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.465 | |
5ckw | ANP | Uncharacterized protein | / | 0.465 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.465 | |
1l3i | SAH | Probable cobalt-precorrin-6B C(15)-methyltransferase (decarboxylating) | / | 0.464 | |
1ol6 | ATP | Aurora kinase A | 2.7.11.1 | 0.464 | |
1s0z | EB1 | Vitamin D3 receptor | / | 0.464 | |
2cmv | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.464 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.464 | |
2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.464 | |
2qkr | IXM | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.464 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.464 | |
3rai | X85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3rk9 | 09Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3s00 | Z60 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.464 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.464 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.464 | |
4j6i | 1JV | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.464 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.464 | |
4q0a | 4OA | Vitamin D3 receptor A | / | 0.464 | |
4yx6 | FMN | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.464 | |
5l8k | ADP | Aurora kinase A | 2.7.11.1 | 0.464 | |
1unh | IXM | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.463 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.463 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2x4f | 16X | Myosin light chain kinase family member 4 | 2.7.11.1 | 0.463 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.463 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.463 | |
3qtw | X3A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
3qtz | X42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
3tm0 | ANP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.463 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.463 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.463 | |
3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.463 | |
4c2u | ANP | DNA helicase | / | 0.463 | |
4eop | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.463 | |
4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.463 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.463 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.463 | |
4kfg | DOO | DNA gyrase subunit B | / | 0.463 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.463 | |
4rf2 | NAP | NADPH dependent R-specific alcohol dehydrogenase | / | 0.463 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.462 | |
1rbm | KT5 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.462 | |
1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.462 | |
1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2a5u | QYT | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2r3f | SC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2r3r | 6SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.462 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.462 | |
3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.462 | |
3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.462 | |
3ibe | L64 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.462 | |
3w0r | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.462 | |
3zrl | ZRL | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.462 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.462 | |
4ruj | VDX | Vitamin D3 receptor A | / | 0.462 | |
4wq4 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.462 | |
5av0 | 47X | Death-associated protein kinase 1 | 2.7.11.1 | 0.462 | |
1b39 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
1g6c | TZP | Thiamine-phosphate synthase | / | 0.461 | |
1lik | ADN | Adenosine kinase | 2.7.1.20 | 0.461 | |
1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.461 | |
1rx8 | NAP | Dihydrofolate reductase | 1.5.1.3 | 0.461 | |
2c6i | DT1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
2jkk | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.461 | |
2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2vti | LZ3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.461 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.461 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.461 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.461 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.461 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.461 | |
3niz | ADP | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.461 | |
3pls | ANP | Macrophage-stimulating protein receptor | 2.7.10.1 | 0.461 | |
3pm0 | BHF | Cytochrome P450 1B1 | / | 0.461 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.461 | |
3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3rpo | 24Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3w0h | W12 | Vitamin D3 receptor | / | 0.461 | |
3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.461 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.461 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
4kxl | 6C6 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | / | 0.461 | |
4l2y | XXK | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.461 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.461 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
3rey | XAC | Adenosine receptor A2a | / | 0.461 | |
1ke9 | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
1lhv | NOG | Sex hormone-binding globulin | / | 0.460 | |
1mq4 | ADP | Aurora kinase A | 2.7.11.1 | 0.460 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
1tj0 | FAD | Bifunctional protein PutA | 1.5.5.2 | 0.460 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.460 | |
2hb8 | MVD | Vitamin D3 receptor | / | 0.460 | |
2hqp | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.460 | |
3koo | 24D | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.460 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.460 | |
3ump | ATP | ATP-dependent 6-phosphofructokinase isozyme 2 | 2.7.1.11 | 0.460 | |
3vt8 | YI3 | Vitamin D3 receptor | / | 0.460 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
4a33 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.460 | |
4ckj | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.460 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
4o4f | ATP | Kinase | / | 0.460 | |
4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.460 | |
5ani | ES4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.460 | |
1e8w | QUE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
1j7l | ADP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.459 | |
1q20 | PLO | Sulfotransferase family cytosolic 2B member 1 | 2.8.2.2 | 0.459 | |
1rkg | VD1 | Vitamin D3 receptor | / | 0.459 | |
1rx5 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
1t86 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.459 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.459 | |
1xkd | NAP | Isocitrate dehydrogenase [NADP] | / | 0.459 | |
2gd0 | MRS | Probable alpha-methylacyl-CoA racemase Mcr (2-methylacyl-CoA racemase) (2-arylpropionyl-CoA epimerase ) | / | 0.459 | |
2gd2 | CAA | Probable alpha-methylacyl-CoA racemase Mcr (2-methylacyl-CoA racemase) (2-arylpropionyl-CoA epimerase ) | / | 0.459 | |
2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.459 | |
2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.459 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.459 | |
2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.459 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.459 | |
3dpd | 41A | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.459 | |
3vf9 | 477 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.459 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.459 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.459 | |
4ge4 | 0KE | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.459 | |
4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.459 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.459 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.459 | |
4ri1 | ACO | UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine N-acetyltransferase | 2.3.1.202 | 0.459 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.459 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.459 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.458 | |
1phh | FAD | p-hydroxybenzoate hydroxylase | / | 0.458 | |
1r0e | DFN | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
1tz8 | DES | Transthyretin | / | 0.458 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2z3u | CRR | Cytochrome P450 | / | 0.458 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
3fwg | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.458 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.458 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.458 | |
3qqf | X07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3r8u | Z31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.458 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.458 | |
3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.458 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
4e37 | NDP | Catalase | 1.11.1.6 | 0.458 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
4ia3 | BIV | Vitamin D3 receptor A | / | 0.458 | |
4lj3 | C2E | Cyclic di-GMP phosphodiesterase YahA | 3.1.4 | 0.458 | |
4nm0 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
4o1p | ANP | Ribonuclease L | / | 0.458 | |
4q72 | FAD | Bifunctional protein PutA | / | 0.458 | |
5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.458 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.458 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.458 | |
1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.457 | |
1dra | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.457 | |
1kgj | FL8 | Transthyretin | / | 0.457 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2b0m | 201 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.457 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.457 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.457 | |
2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.457 | |
2zlc | VDX | Vitamin D3 receptor | / | 0.457 | |
3ics | ADP | Coenzyme A disulfide reductase | / | 0.457 | |
3igg | EFQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3qf9 | NM8 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3sru | Q26 | Dihydrofolate reductase | 1.5.1.3 | 0.457 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.457 | |
3um5 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.457 | |
4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.457 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.457 | |
5auu | LU2 | Death-associated protein kinase 1 | 2.7.11.1 | 0.457 | |
5ify | UMP | Glucose-1-phosphate thymidylyltransferase | / | 0.457 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1ie9 | VDX | Vitamin D3 receptor | / | 0.456 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
1rj6 | AZM | Carbonic anhydrase 14 | 4.2.1.1 | 0.456 | |
1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.456 | |
2oj9 | BMI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.456 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.456 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.456 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.456 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
2zb4 | 5OP | Prostaglandin reductase 2 | 1.3.1.48 | 0.456 | |
2zbz | VDX | Vitamin D3 dihydroxylase | / | 0.456 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.456 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
3e9y | FAB | Acetolactate synthase, chloroplastic | 2.2.1.6 | 0.456 | |
3f5u | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
3fy9 | XCF | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
3owk | 18E | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.456 | |
3vwe | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.456 | |
3w0y | DS4 | Vitamin D3 receptor | / | 0.456 | |
3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.456 | |
3wbb | NAP | Meso-diaminopimelate D-dehydrogenase | / | 0.456 | |
4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.456 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4c5b | ADP | D-alanine--D-alanine ligase B | 6.3.2.4 | 0.456 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.456 | |
4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
4gst | GTD | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.456 | |
4lrj | ANP | Uncharacterized protein | / | 0.456 | |
4oau | ADP | 2-5A-dependent ribonuclease | 3.1.26 | 0.456 | |
5dmz | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.456 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.456 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
1lhw | ESM | Sex hormone-binding globulin | / | 0.455 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.455 | |
1ung | ALH | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.455 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2f02 | ATP | Tagatose-6-phosphate kinase | / | 0.455 | |
2pmo | HMD | Protein kinase 7 | / | 0.455 | |
2r3i | SCF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.455 | |
2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.455 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
3iqf | E4M | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.455 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.455 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.455 | |
3mia | ANP | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.455 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.455 | |
3w0c | 6DS | Vitamin D3 receptor | / | 0.455 | |
3w0o | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.455 | |
3zux | TCH | Transporter | / | 0.455 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.455 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.455 | |
4ho8 | THM | Glucose-1-phosphate thymidylyltransferase | / | 0.455 | |
4hxy | NDP | Plm1 | / | 0.455 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.455 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.455 | |
4zoh | FAD | Putative oxidoreductase FAD-binding subunit | / | 0.455 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.455 | |
5bpf | ADP | D-alanine--D-alanine ligase | / | 0.455 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.455 | |
5jqb | IBP | Envelope glycoprotein | / | 0.455 | |
1fby | REA | Retinoic acid receptor RXR-alpha | / | 0.454 | |
1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
1nuu | NAD | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 | / | 0.454 | |
1nvt | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.454 | |
1sn5 | T3 | Transthyretin | / | 0.454 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.454 | |
2c69 | CT8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.454 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
2oby | NAP | Quinone oxidoreductase PIG3 | 1 | 0.454 | |
2r3k | SCQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2vf0 | F89 | Thymidylate synthase | / | 0.454 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.454 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.454 | |
2zl9 | VDA | Vitamin D3 receptor | / | 0.454 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.454 | |
3ict | ADP | Coenzyme A disulfide reductase | / | 0.454 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3r6x | X84 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3uix | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.454 | |
4bqp | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.454 | |
4cax | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.454 | |
4d4s | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4h6p | FMN | Chromate reductase | / | 0.454 | |
4jv6 | 18F | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.454 | |
4xhg | ADP | Uncharacterized protein | / | 0.454 | |
4ysw | FAD | Xanthine dehydrogenase/oxidase | / | 0.454 | |
1ay0 | TPP | Transketolase 1 | 2.2.1.1 | 0.453 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
1j39 | UPG | DNA beta-glucosyltransferase | / | 0.453 | |
1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.453 | |
2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.453 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.453 | |
2xj2 | 985 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
3aox | EMH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
3fri | SAH | 16S rRNA methylase | / | 0.453 | |
3ig7 | EFP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.453 | |
3mb6 | 01I | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.453 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3tiz | 3TI | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
4cdm | FO1 | Deoxyribodipyrimidine photolyase | / | 0.453 | |
4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.453 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
4fkq | 42K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.453 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
4j0r | 1H2 | Bromodomain-containing protein 4 | / | 0.453 | |
4q5h | ANP | Protein kinase OspG | 2.7 | 0.453 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.453 | |
4xiw | AZM | Carbonic anhydrase, alpha type | / | 0.453 | |
5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.453 | |
1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.452 | |
1txi | TX5 | Vitamin D3 receptor | / | 0.452 | |
2b9w | FAD | Putative aminooxidase | / | 0.452 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
2pg0 | FAD | Acyl-CoA dehydrogenase | / | 0.452 | |
2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.452 | |
2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
2vtj | LZ4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
3csd | EMO | Putative ketoacyl reductase | 1.3.1 | 0.452 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3dga | RJ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.452 | |
3f47 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.452 | |
3iro | 2CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.452 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.452 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.452 | |
3sh2 | 5DR | Dihydrofolate reductase | 1.5.1.3 | 0.452 | |
3w0n | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.452 | |
3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.452 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
4az3 | S35 | Lysosomal protective protein | 3.4.16.5 | 0.452 | |
4bbh | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.452 | |
4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.452 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.452 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.452 | |
4lxh | C1E | Alpha/beta hydrolase fold | / | 0.452 | |
4o2b | LOC | Tubulin beta-2B chain | / | 0.452 | |
4qys | PLR | Tryptophan synthase beta chain 2 | 4.2.1.20 | 0.452 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.452 | |
1f28 | UMP | Thymidylate synthase | 2.1.1.45 | 0.451 | |
1nmd | ATP | Major actin | / | 0.451 | |
1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.451 | |
1uyr | D1L | Acetyl-CoA carboxylase | / | 0.451 | |
2ahr | NAP | Pyrroline-5-carboxylate reductase | / | 0.451 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
2hc4 | VDX | Vitamin D3 receptor A | / | 0.451 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
2ph5 | NAD | Homospermidine synthase | / | 0.451 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
2r3l | SCW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.451 | |
3f46 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.451 | |
3h4v | NAP | Pteridine reductase 1 | 1.5.1.33 | 0.451 | |
3i81 | EBI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.451 | |
3k3b | ADP | Kinesin-like protein KIF11 | / | 0.451 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3m7r | VDX | Vitamin D3 receptor | / | 0.451 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.451 | |
3nwy | GTP | Uridylate kinase | / | 0.451 | |
3qtx | X43 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3roy | 22Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3vt6 | 5YI | Vitamin D3 receptor | / | 0.451 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.451 | |
4a9t | A9T | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
4an9 | 2P7 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.451 | |
4awq | 592 | Heat shock protein HSP 90-alpha | / | 0.451 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.451 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
4bw1 | S5B | Bromodomain-containing protein 4 | / | 0.451 | |
4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.451 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.451 | |
4dti | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.451 | |
4g1z | 0VP | Vitamin D3 receptor A | / | 0.451 | |
4gdy | 0X1 | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.451 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.451 | |
4isk | UMP | Thymidylate synthase | / | 0.451 | |
4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.451 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.451 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.451 | |
4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.451 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
4uux | APR | CinA-like protein | / | 0.451 | |
4wuc | ANP | DNA gyrase subunit B | / | 0.451 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.451 | |
5dn3 | ATP | Aurora kinase A | 2.7.11.1 | 0.451 | |
5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.451 | |
5ecc | NAP | Dehydrofolate reductase type I | / | 0.451 | |
1hii | C20 | Gag-Pol polyprotein | / | 0.450 | |
1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.450 | |
1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.450 | |
1ruo | CMP | cAMP-activated global transcriptional regulator CRP | / | 0.450 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.450 | |
2bhh | RYU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2byc | FMN | Blue-light receptor of the BLUF-family | / | 0.450 | |
2has | C3O | Vitamin D3 receptor | / | 0.450 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
2j8z | NAP | Quinone oxidoreductase PIG3 | 1 | 0.450 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
2uzo | C62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2ww4 | ADP | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.450 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.450 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
3iw1 | ASD | Steroid C26-monooxygenase | 1.14.13.141 | 0.450 | |
3mnr | SD1 | Heat shock protein HSP 90-alpha | / | 0.450 | |
3n7u | NAD | Formate dehydrogenase, chloroplastic/mitochondrial | / | 0.450 | |
3pj8 | 404 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3ufn | ROC | Gag-Pol polyprotein | / | 0.450 | |
3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.450 | |
3vt9 | YI4 | Vitamin D3 receptor | / | 0.450 | |
3vtb | TKA | Vitamin D3 receptor | / | 0.450 | |
3w5t | LHP | Vitamin D3 receptor | / | 0.450 | |
4b12 | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.450 | |
4c5c | ATP | D-alanine--D-alanine ligase B | 6.3.2.4 | 0.450 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.450 | |
4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4g20 | 484 | Vitamin D3 receptor A | / | 0.450 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.450 | |
4ite | TEY | Vitamin D3 receptor | / | 0.450 | |
4wlu | NAD | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.450 | |
5c88 | COA | N-alpha-acetyltransferase | / | 0.450 | |
5d4v | SAH | Uncharacterized protein MJ0489 | / | 0.450 | |
1bvr | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.449 | |
1dg5 | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
1dss | NAD | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.449 | |
1ep3 | FAD | Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit | / | 0.449 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
1og5 | SWF | Cytochrome P450 2C9 | / | 0.449 | |
1rkd | ADP | Ribokinase | / | 0.449 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.449 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.449 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.449 | |
2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.449 | |
3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.449 | |
3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.449 | |
3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.449 | |
3ogq | AB1 | Pol polyprotein | / | 0.449 | |
3s7a | 684 | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.449 | |
3ule | C69 | Actin-related protein 3 | / | 0.449 | |
3upy | FOM | Oxidoreductase, putative | / | 0.449 | |
3vwd | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.449 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.449 | |
4fkp | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
4g6h | NAI | Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial | 1.6.5.9 | 0.449 | |
4hfm | NAP | 2-alkenal reductase (NADP(+)-dependent) | / | 0.449 | |
4itf | TFY | Vitamin D3 receptor | / | 0.449 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.449 | |
4nmd | FDA | Bifunctional protein PutA | / | 0.449 | |
4pkl | 1GH | Uncharacterized protein | / | 0.449 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1jnk | ANP | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.448 | |
1v1a | KDG | 2-dehydro-3-deoxygluconokinase | 2.7.1.45 | 0.448 | |
2c27 | ACO | Mycothiol acetyltransferase | 2.3.1.189 | 0.448 | |
2pvr | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
2rhr | EMO | Putative ketoacyl reductase | 1.3.1 | 0.448 | |
3c1x | CKK | Hepatocyte growth factor receptor | 2.7.10.1 | 0.448 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3etg | GWD | Glutamate dehydrogenase 1, mitochondrial | 1.4.1.3 | 0.448 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3iel | U5P | Ribonuclease TTHA0252 | 3.1 | 0.448 | |
3mb7 | 14I | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.448 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
3qzf | X66 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3r1q | X75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3r28 | XA0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3r37 | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.448 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
3w0i | O11 | Vitamin D3 receptor | / | 0.448 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.448 | |
3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.448 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.448 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.448 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
4h4x | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.448 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.448 | |
4nu6 | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.448 | |
4wlo | NAI | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.448 | |
4zhx | C1V | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | / | 0.448 | |
4zhx | C1V | 5'-AMP-activated protein kinase subunit beta-1 | / | 0.448 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
5ccc | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.448 | |
1drb | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1dz4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
1ee0 | CAA | 2-pyrone synthase | / | 0.447 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
1tj2 | FAD | Bifunctional protein PutA | 1.5.5.2 | 0.447 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
2hbh | XE4 | Vitamin D3 receptor A | / | 0.447 | |
2hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.447 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
2p5u | NAD | UDP-glucose 4-epimerase | / | 0.447 | |
2qbn | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
2yk2 | YJW | Heat shock protein HSP 90-alpha | / | 0.447 | |
2zax | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.447 | |
3dmh | SAM | Probable ribosomal RNA small subunit methyltransferase | / | 0.447 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3rzb | 02Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3uqd | ATP | ATP-dependent 6-phosphofructokinase isozyme 2 | 2.7.1.11 | 0.447 | |
3vtc | TK3 | Vitamin D3 receptor | / | 0.447 | |
3w0a | DS5 | Vitamin D3 receptor | / | 0.447 | |
3wbl | PDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3zbx | 6XE | Hepatocyte growth factor receptor | 2.7.10.1 | 0.447 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
4geb | 0LD | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.447 | |
4iui | 1GQ | Estrogen receptor | / | 0.447 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.447 | |
4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.447 | |
4wh2 | ADP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.447 | |
4xsr | UPG | Alr3699 protein | / | 0.447 | |
1lny | IMO | Adenylosuccinate synthetase isozyme 1 | / | 0.446 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.446 | |
1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
1y4l | SVR | Basic phospholipase A2 homolog 2 | / | 0.446 | |
1zid | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.446 | |
2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.446 | |
2cgp | CMP | cAMP-activated global transcriptional regulator CRP | / | 0.446 | |
2dcn | ADP | 2-keto-3-deoxy-gluconate kinase | / | 0.446 | |
2ham | C33 | Vitamin D3 receptor | / | 0.446 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
2q5q | TPW | Indole-3-pyruvate decarboxylase | 4.1.1.74 | 0.446 | |
2xan | ANP | Inositol-pentakisphosphate 2-kinase | 2.7.1.158 | 0.446 | |
2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.446 | |
2xy9 | 3ES | Angiotensin-converting enzyme | 3.2.1 | 0.446 | |
3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.446 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.446 | |
3eem | 53V | Uncharacterized protein | / | 0.446 | |
3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.446 | |
3glm | COO | Glutaconyl-CoA decarboxylase alpha subunit | / | 0.446 | |
3hko | ANP | Calcium/calmodulin-dependent protein kinase with a kinase domain and 2 calmodulin-like EF hands | / | 0.446 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.446 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.446 | |
3mtl | FEF | Cyclin-dependent kinase 16 | 2.7.11.22 | 0.446 | |
3owj | 1EL | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
3qtq | X35 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.446 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.446 | |
4f7l | 0SO | Cyclin-dependent kinase 8 | 2.7.11.22 | 0.446 | |
4f9c | 0SX | Cell division cycle 7-related protein kinase | 2.7.11.1 | 0.446 | |
4fvq | ATP | Tyrosine-protein kinase JAK2 | / | 0.446 | |
4g1d | 0VK | Vitamin D3 receptor A | / | 0.446 | |
4g2h | 0VQ | Vitamin D3 receptor A | / | 0.446 | |
4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.446 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
4p6w | MOF | Glucocorticoid receptor | / | 0.446 | |
4ruo | BIV | Vitamin D3 receptor A | / | 0.446 | |
4xiv | ACP | Chemotaxis protein CheA | 2.7.13.3 | 0.446 | |
4ylh | YE1 | (3,5-dihydroxyphenyl)acetyl-CoA 1,2-dioxygenase | / | 0.446 | |
4z07 | PCG | cGMP-dependent protein kinase 1 | 2.7.11.12 | 0.446 | |
4zol | ACP | Tubulin tyrosine ligase | / | 0.446 | |
5bp9 | SAH | Putative methyltransferase protein | / | 0.446 | |
5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.446 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.446 | |
1e1x | NW1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.445 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.445 | |
1j3j | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.445 | |
1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.445 | |
1ztf | XYA | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.445 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2aib | ERG | Beta-elicitin cinnamomin | / | 0.445 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2gcg | NDP | Glyoxylate reductase/hydroxypyruvate reductase | 1.1.1.79 | 0.445 | |
2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
2qhc | AB1 | Protease | / | 0.445 | |
2r3o | 2SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2x81 | ZZL | Aurora kinase A | 2.7.11.1 | 0.445 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.445 | |
2yvj | NAI | Ferredoxin reductase | / | 0.445 | |
3cbs | R12 | Cellular retinoic acid-binding protein 2 | / | 0.445 | |
3dr1 | C5D | Vitamin D3 receptor A | / | 0.445 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.445 | |
3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.445 | |
3pm9 | FAD | Putative oxidoreductase | / | 0.445 | |
3qqg | X06 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3rah | O1Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.445 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.445 | |
4ffr | ATP | Uncharacterized protein | / | 0.445 | |
4fhh | 0U3 | Vitamin D3 receptor A | / | 0.445 | |
4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4gkv | NAD | Alcohol dehydrogenase, propanol-preferring | 1.1.1.1 | 0.445 | |
4hy6 | FJ1 | Heat shock protein HSP 90-alpha | / | 0.445 | |
4ix6 | ADP | Uncharacterized protein | / | 0.445 | |
4j71 | 1JX | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.445 | |
4oae | CLM | Uncharacterized protein | / | 0.445 | |
1ikv | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
1osv | CHC | Bile acid receptor | / | 0.444 | |
1rbz | KT5 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.444 | |
1rkh | VD2 | Vitamin D3 receptor | / | 0.444 | |
1tj1 | FAD | Bifunctional protein PutA | 1.5.5.2 | 0.444 | |
1v9a | SAH | Uncharacterized protein | / | 0.444 | |
1xdd | AAY | Integrin alpha-L | / | 0.444 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
2bkz | SBC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2bl9 | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.444 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.444 | |
2ddo | ATP | Pyridoxine/pyridoxal/pyridoxamine kinase | / | 0.444 | |
2eq7 | NAD | Dihydrolipoyl dehydrogenase | / | 0.444 | |
2gtk | 208 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
3bhi | NAP | Carbonyl reductase [NADPH] 1 | 1.1.1.184 | 0.444 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.444 | |
3jw3 | TOP | Dihydrofolate reductase | / | 0.444 | |
3pxy | JWS | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3ql8 | X01 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3qwj | X6A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3tm5 | SFG | Uncharacterized protein | / | 0.444 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
3w5r | LOA | Vitamin D3 receptor | / | 0.444 | |
4b10 | NHW | Glycylpeptide N-tetradecanoyltransferase | / | 0.444 | |
4bde | CWS | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.444 | |
4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
4dlb | NAD | S-(hydroxymethyl)glutathione dehydrogenase | / | 0.444 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.444 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.444 | |
4i6g | FAD | Cryptochrome-2 | / | 0.444 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.444 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.444 | |
4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.444 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.444 | |
4ocp | ADP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.444 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.444 | |
1d2s | DHT | Sex hormone-binding globulin | / | 0.443 | |
1hvy | D16 | Thymidylate synthase | 2.1.1.45 | 0.443 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.443 | |
1q4x | G24 | Thyroid hormone receptor beta | / | 0.443 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
1sxj | ADP | Replication factor C subunit 5 | / | 0.443 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.443 | |
1uyu | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1yqj | 6NP | Mitogen-activated protein kinase 14 | / | 0.443 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.443 | |
2drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.443 | |
2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
2pwu | GUN | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.443 | |
2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2uzh | IPE | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | / | 0.443 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2yww | ATP | Aspartate carbamoyltransferase regulatory chain | / | 0.443 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
3c4z | ADP | Rhodopsin kinase | / | 0.443 | |
3chw | ATP | Major actin | / | 0.443 | |
3cis | ATP | Universal stress protein Rv2623 | / | 0.443 | |
3cr3 | ADP | PTS-dependent dihydroxyacetone kinase, ADP-binding subunit DhaL | 2.7 | 0.443 | |
3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.443 | |
3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.443 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.443 | |
3iaf | TPP | Benzaldehyde lyase | / | 0.443 | |
3lfc | Z86 | Mitogen-activated protein kinase 14 | / | 0.443 | |
3nr4 | PYV | Abscisic acid receptor PYL2 | / | 0.443 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.443 | |
3qgt | CP6 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.443 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.443 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.443 | |
3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.443 | |
3vt3 | VDX | Vitamin D3 receptor | / | 0.443 | |
4ajm | 3A6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4ffl | ADP | Uncharacterized protein | / | 0.443 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
4k41 | ATP | Actin, alpha skeletal muscle | / | 0.443 | |
4n6b | COA | Uncharacterized protein | / | 0.443 | |
4q73 | FAD | Bifunctional protein PutA | / | 0.443 | |
4qms | 1N1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
4rup | H97 | Vitamin D3 receptor A | / | 0.443 | |
4xcv | NDP | Probable hydroxyacid dehydrogenase protein | / | 0.443 | |
4yt5 | H4M | H(2)-forming methylenetetrahydromethanopterin dehydrogenase-related protein MJ1338 | / | 0.443 | |
1cbq | RE9 | Cellular retinoic acid-binding protein 2 | / | 0.442 | |
1dkf | BMS | Retinoic acid receptor alpha | / | 0.442 | |
1eet | BFU | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.442 | |
1guf | NDP | Enoyl-[acyl-carrier-protein] reductase 1, mitochondrial | 1.3.1.10 | 0.442 | |
1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
1ojt | FAD | Dihydrolipoyl dehydrogenase | / | 0.442 | |
1pag | FMP | Antiviral protein I | 3.2.2.22 | 0.442 | |
1pmv | 537 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
1r6w | 164 | o-succinylbenzoate synthase | / | 0.442 | |
2b00 | GCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.442 | |
2fzh | DH1 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
2hs2 | 017 | Protease | / | 0.442 | |
2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
2j3i | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.442 | |
2jdv | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.442 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
2pmd | GNP | Translation initiation factor 2 subunit gamma | / | 0.442 | |
2q29 | ACO | Oxalyl-CoA decarboxylase | 4.1.1.8 | 0.442 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.442 | |
2y0j | AXC | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
3bea | IXH | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.442 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.442 | |
3eej | 53R | Uncharacterized protein | / | 0.442 | |
3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.442 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
3icr | FAD | Coenzyme A disulfide reductase | / | 0.442 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.442 | |
3l9h | EMQ | Kinesin-like protein KIF11 | / | 0.442 | |
3lu8 | IQX | Serum albumin | / | 0.442 | |
3r8v | Z62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3t2k | FAD | Sulfide-quinone reductase | / | 0.442 | |
3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.442 | |
3vth | APC | Carbamoyltransferase | / | 0.442 | |
4aqk | ADP | Inositol-pentakisphosphate 2-kinase | 2.7.1.158 | 0.442 | |
4cvb | PQQ | Alcohol dehydrogenase | / | 0.442 | |
4dea | NHI | Aurora kinase A | 2.7.11.1 | 0.442 | |
4eiy | ZMA | Adenosine receptor A2a | / | 0.442 | |
4fc0 | 0T2 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.442 | |
4fks | 46K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4fp9 | SAM | 5-methylcytosine rRNA methyltransferase NSUN4 | 2.1.1 | 0.442 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.442 | |
4ia1 | BIV | Vitamin D3 receptor A | / | 0.442 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.442 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
4l8u | 9AZ | Serum albumin | / | 0.442 | |
4nxu | ADP | Mitochondrial dynamics protein MID51 | / | 0.442 | |
4pd6 | URI | Nucleoside permease | / | 0.442 | |
4u9z | COA | Alpha-tubulin N-acetyltransferase 1 | / | 0.442 | |
4xiv | ADP | Chemotaxis protein CheA | 2.7.13.3 | 0.442 | |
5eai | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
5fwn | NAP | Putative dehydrogenase | / | 0.442 | |
4ea3 | 0NN | Nociceptin receptor | / | 0.442 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.442 | |
1g1l | DAU | Glucose-1-phosphate thymidylyltransferase | / | 0.441 | |
1g67 | TZP | Thiamine-phosphate synthase | / | 0.441 | |
1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.441 | |
1ke5 | LS1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1nq7 | ARL | Nuclear receptor ROR-beta | / | 0.441 | |
1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1v59 | FAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.441 | |
1zhw | HC2 | Oxysterol-binding protein homolog 4 | / | 0.441 | |
2bkk | ADP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.441 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.441 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.441 | |
2w1g | L0G | Aurora kinase A | 2.7.11.1 | 0.441 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.441 | |
3au8 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic | 1.1.1.267 | 0.441 | |
3c13 | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.441 | |
3oog | YTP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
3r3b | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.441 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3rpr | 25Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3tnl | NAD | Shikimate dehydrogenase (NADP(+)) | / | 0.441 | |
3w0j | T08 | Vitamin D3 receptor | / | 0.441 | |
4b1v | LAB | Actin, alpha skeletal muscle | / | 0.441 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.441 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
4e20 | 0MY | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4hnc | 0UT | Mandelate racemase | / | 0.441 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.441 | |
4ibm | IR1 | Insulin receptor | 2.7.10.1 | 0.441 | |
4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.441 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
4o8a | FAD | Bifunctional protein PutA | 1.2.1.88 | 0.441 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.441 | |
4qi7 | FAD | Cellobiose dehydrogenase | / | 0.441 | |
4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.441 | |
4upj | U04 | Gag-Pol polyprotein | / | 0.441 | |
4wuo | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.441 | |
4xgx | ADP | FAD:protein FMN transferase | / | 0.441 | |
4yr9 | NAD | L-threonine 3-dehydrogenase, mitochondrial | 1.1.1.103 | 0.441 | |
4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.441 | |
5cwa | 0GA | Anthranilate synthase component 1 | 4.1.3.27 | 0.441 | |
5hi2 | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.441 | |
3sn6 | P0G | Beta-2 adrenergic receptor | / | 0.441 | |
1c1d | NAI | Phenylalanine dehydrogenase | / | 0.440 | |
1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
1mer | DMQ | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1n71 | COA | Aac(6')-Ii protein | / | 0.440 | |
1omo | NAD | Alanine dehydrogenase | / | 0.440 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.440 | |
1tdr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2ceo | T44 | Thyroxine-binding globulin | / | 0.440 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
2ilt | NN1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
2ouy | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.440 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.440 | |
2yjx | YJX | Heat shock protein HSP 90-alpha | / | 0.440 | |
2yk2 | YJX | Heat shock protein HSP 90-alpha | / | 0.440 | |
3a78 | 3EV | Vitamin D3 receptor | / | 0.440 | |
3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
3clh | NAD | 3-dehydroquinate synthase | 4.2.3.4 | 0.440 | |
3cwk | REA | Cellular retinoic acid-binding protein 2 | / | 0.440 | |
3eek | 53S | Uncharacterized protein | / | 0.440 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.440 | |
3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.440 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
3mzi | FMN | Activator of photopigment and puc expression | / | 0.440 | |
3nj0 | PYV | Abscisic acid receptor PYL2 | / | 0.440 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.440 | |
3q9z | TXQ | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3qzi | X72 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3r3d | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.440 | |
3rpy | 27Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.440 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.440 | |
4a31 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.440 | |
4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
4axd | ANP | Inositol-pentakisphosphate 2-kinase | 2.7.1.158 | 0.440 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.440 | |
4er7 | AW3 | Histone-lysine N-methyltransferase, H3 lysine-79 specific | 2.1.1.43 | 0.440 | |
4ez8 | DHF | Thymidylate synthase | 2.1.1.45 | 0.440 | |
4ivd | 15T | Tyrosine-protein kinase JAK1 | / | 0.440 | |
4kvm | SER_ALA_SER_GLU_1XE | N-terminal acetyltransferase A complex catalytic subunit ard1 | 2.3.1.88 | 0.440 | |
4l4x | NDP | AmphI | / | 0.440 | |
4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
4m15 | ADP | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.440 | |
4o4e | ATP | Kinase | / | 0.440 | |
4ocv | ANP | Aminoglycoside phosphotransferase | / | 0.440 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.440 | |
5ag6 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.440 | |
5eyp | LOC | Tubulin beta chain | / | 0.440 | |
5fwg | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.440 |